Scientists from the University of Minnesota have found a promising way to improve cancer treatments by boosting the body’s natural defense cells, called natural killer (NK) cells, with vitamin B3 (nicotinamide).
These NK cells, which are part of the immune system, act as frontline fighters against diseases, including cancer. In this study, treating NK cells with vitamin B3 made them more effective at targeting and destroying cancer cells, offering new hope for patients with difficult-to-treat blood cancers.
Why Previous Treatments Struggled
Using NK cells to treat blood cancers like leukemia and lymphoma has been explored before, but the results have been inconsistent. While some patients benefited, others didn’t respond, particularly those whose cancers had already resisted standard therapies. This highlighted the need to find ways to make NK cell therapy more reliable and effective.
The Role of Vitamin B3
The innovative twist in this new approach lies in using vitamin B3, a nutrient commonly associated with energy production in the body.
In the lab, researchers treated NK cells with vitamin B3 and observed remarkable improvements. These enhanced cells were better at identifying cancer cells and had increased durability and efficiency in destroying them.
The scientists also combined these boosted NK cells with another cancer-fighting drug. The combination showed encouraging results in a small group of patients. Among 19 participants with a challenging type of lymphoma, 11 achieved complete recovery, and three experienced partial recovery within just 28 days.
How Vitamin B3 Helps
Vitamin B3 is known for its health benefits, including preventing pellagra, a severe illness caused by a deficiency in the vitamin. In this study, vitamin B3 did more than boost the NK cells’ energy.
It also protected these cells from damage, helping them survive longer and maintain their cancer-fighting abilities. This dual effect made the NK cells stronger and more efficient in their battle against cancer.
What the Results Mean
This research suggests that adding vitamin B3 to NK cell therapy could significantly improve outcomes for patients with blood cancers that are resistant to other treatments. The findings are particularly exciting because they demonstrate that a well-known, safe vitamin can enhance a natural and already powerful immune response.
What’s Next?
The next step for the researchers is to test this approach on a larger group of patients in clinical trials. If these trials confirm the initial results, this vitamin-boosted NK cell therapy could become a valuable new tool for treating blood cancers.
This breakthrough highlights the potential of combining natural immune mechanisms with simple, safe treatments to develop more effective cancer therapies. It also underscores the importance of continued research into how nutrients like vitamin B3 can play a role in fighting complex diseases.
The study, published in Science Translational Medicine, offers a glimpse of a future where natural and enhanced therapies work together to tackle even the most stubborn cancers.
For more information about cancer, please see recent studies about the link between dairy food and certain cancers and this common food chemicals may cause cancer.
For more information about cancer, please see recent studies that plant-based diets may reduce risk of colorectal cancer in men, and Low-fat diet may help stop cancer growth.
Copyright © 2025 Knowridge Science Report. All rights reserved.
